Power wheelchair — group 2 denied due to quantity / dose limits by UnitedHealthcare?

Under UnitedHealthcare's Commercial medical policy, mobility devices including manual wheelchairs, electric wheelchairs, transfer chairs, scooters/power-operated vehicles (POV), canes, and walkers are a covered health care service when medically necessary. The policy aligns with CMS LCD L33789, which establishes that the beneficiary must have a mobility limitation that significantly impairs his/her ability to participate in one or more mobility-related activities of daily living (MRADLs) such as toileting, feeding, dressing, grooming, and bathing in customary locations in the home — a limitation that prevents the beneficiary from accomplishing an MRADL entirely, places the beneficiary at heightened risk of morbidity or mortality, or prevents completing an MRADL within a reasonable time frame ; additionally, the mobility limitation cannot be sufficiently and safely resolved by an appropriately fitted cane or walker, and the beneficiary does not have sufficient upper extremity function to self-propel an optimally-configured manual wheelchair in the home to perform MRADLs during a typical day. Use of a power wheelchair must significantly improve the beneficiary's ability to participate in MRADLs and the beneficiary will use it in the home (for severe cognitive/physical impairments, participation in MRADLs may require caregiver assistance), and the beneficiary has not expressed an unwillingness to use a power wheelchair in the home. For a Group 2 standard PWC, a Group 2 PWC (K0820, K0821, K0822, K0823, K0824, K0825, K0826, K0827, K0828, K0829) is covered if all of the coverage criteria (a)-(e) for a PWC are met and the wheelchair is appropriate for the beneficiary's weight. For a Group 2 Single Power Option PWC, all coverage criteria (a)-(e) must be met, plus the beneficiary meets coverage criteria for a power tilt or recline seating system OR requires a drive control interface other than a hand or chin-operated standard proportional joystick (examples include head control, sip and puff, switch control) , and a specialty evaluation must be performed by a licensed/certified medical professional (PT, OT, or practitioner with rehab wheelchair training) with no financial relationship with the supplier, and the wheelchair must be provided by a supplier that employs a RESNA-certified Assistive Technology Professional (ATP) with direct, in-person involvement in the wheelchair selection. DME has a reasonable useful lifetime (RUL) of 5 years , and payment is made for only one wheelchair at a time; backup chairs are denied as not reasonable and necessary.

- **Document MRADL impact in detail**: Provide a clinician note specifying which MRADLs (toileting, feeding, dressing, grooming, bathing) the patient cannot complete or completes only with heightened morbidity/mortality risk, directly mapping to the LCD L33789 definition of a qualifying mobility limitation . - **Stepwise rule-out of lesser devices**: Submit PT/OT documentation explaining why a cane, walker, and optimally-configured manual wheelchair each fail — addressing strength, endurance, ROM, coordination, pain, or upper-extremity deformity per the LCD's enumerated upper-extremity assessment factors (strength, endurance, range of motion, coordination, pain, deformity or absence of one or both upper extremities) . - **Provide compliant face-to-face and WOPD**: Attach the dated face-to-face mobility examination note and the signed Standard Written Order before delivery; cite Final Rule 1713's requirement of a face-to-face encounter and Written Order Prior to Delivery as satisfied. - **Include RESNA ATP and independent specialty evaluation**: For Group 2 Single Power Option chairs, include both the ATP credential attestation and the independent PT/OT specialty evaluation, satisfying the requirement that a licensed PT/OT with no financial relationship to the supplier perform the specialty evaluation and that a RESNA-certified ATP have direct involvement in wheelchair selection . - **Demonstrate in-home use**: Document home assessment showing adequate access between rooms and maneuvering space, and explicitly state the device will be used in the home to meet the requirement that the beneficiary's home provides adequate access and that the power wheelchair will significantly improve the beneficiary's ability to participate in MRADLs in the home . - **Justify Group 2 over Group 1**: If denied as needing only a Group 1, document the patient's weight against capacity limits or, for Single Power Option, the medical necessity of power tilt/recline (e.g., pressure ulcer risk, inability to perform a functional weight shift) or alternative drive control interface per LCD L33789 Group 2 Single Power Option criteria including need for non-standard drive control such as head control, sip and puff, or switch control . - **Replacement vs. repair**: For replacement requests, document the 5-year RUL and that the existing chair cannot be repaired or no longer meets the patient's needs, citing the 5-year reasonable useful lifetime standard and UHC's allowance for upgrades when the member's condition changes (e.g., impaired function necessitates an upgrade to a power wheelchair from a manual one) .

## Why UnitedHealthcare Denied Your Group 2 Power Wheelchair Under "Quantity Limits"

Quantity-limit denials for durable medical equipment like Group 2 power wheelchairs usually mean UHC believes the member received the same or equivalent equipment within a defined replacement window, or that the quantity or configuration of components exceeds plan limits. These denials often arise when a replacement wheelchair is requested before the insurer's standard replacement interval has elapsed, or when accessories or upgrades are bundled in a way UHC codes as exceeding approved quantities.

## Why This Denial Is Appealable

Quantity limits are not absolute. Federal and plan rules allow exceptions when the existing equipment is lost, stolen, irreparably damaged, or when the member's medical condition has materially changed in a way that makes the prior equipment clinically inadequate. If any of these circumstances apply, the quantity-limit denial can be overturned on appeal.

## Federal Appeal Framework

• Internal appeal: ERISA §503 governs employer-sponsored plans; state law governs fully insured plans. File within the deadline on your EOB.
• External review: ACA §2719 guarantees access to independent external review after a final internal denial. The external reviewer is not affiliated with UHC.
• Expedited review: Available when delay poses risk to health or mobility function.
• Window: Request external review within four months of the final adverse determination.

## Concrete Appeal Steps

1. Obtain the denial letter and identify the specific quantity-limit rule UHC cited. 2. Gather documentation showing the reason for early replacement: damage report, police report for theft, or clinical records showing changed medical status. 3. Have your prescribing physician document the clinical reason the existing equipment is no longer adequate. 4. Submit a written internal appeal with supporting documentation. 5. Escalate to external review if the internal appeal is denied.

## Documentation to Gather

• Records of the prior wheelchair (purchase date, condition, failure or damage documentation)
• Physician or therapist assessment documenting changed medical status or equipment inadequacy
• Photographs or repair-company assessment confirming the prior equipment cannot be cost-effectively repaired
• Prescriber letter of medical necessity explaining the clinical justification for replacement
• Any relevant plan language or UHC policy excerpt regarding replacement exceptions

## Criteria-Mapping Structure

Review UHC's published DME replacement-frequency policy. For each exception pathway it lists (damage, loss, clinical change), provide a point-by-point factual response using dated records from your chart and the equipment history. A direct one-to-one mapping of policy criteria to documented facts is the strongest form an appeal can take.